Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
about
Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk ReductionResveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular Diseasesω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary RelevanceVitamin E function and requirements in relation to PUFAThe impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysisExperimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseasesOmega-3s and cardiovascular health.Nutrient reference value: non-communicable disease endpoints--a conference reportEmerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectivesOverview of prescription omega-3 fatty acid products for hypertriglyceridemiaComparison of free serum oxylipin concentrations in hyper- vs. normolipidemic menA Comparative Overview of Prescription Omega-3 Fatty Acid ProductsEnhanced cognitive function and antidepressant-like effects after krill oil supplementation in rats.U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008.An oil containing EPA and DHA from transgenic Camelina sativa to replace marine fish oil in feeds for Atlantic salmon (Salmo salar L.): Effects on intestinal transcriptome, histology, tissue fatty acid profiles and plasma biochemistryThe 2015 Dutch food-based dietary guidelines.The effects of omega-3 fatty acid supplementation on dexamethasone-induced muscle atrophy.Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled studySaturated Fatty Acids and Cardiovascular Disease: Replacements for Saturated Fat to Reduce Cardiovascular Risk.Genetic predisposition scores for dyslipidaemia influence plasma lipid concentrations at baseline, but not the changes after controlled intake of n-3 polyunsaturated fatty acids.Increase of EPA-derived hydroxy, epoxy and dihydroxy fatty acid levels in human plasma after a single dose of long-chain omega-3 PUFA.Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipinsAcute administration of n-3 rich triglyceride emulsions provides cardioprotection in murine models after ischemia-reperfusionComparative analysis of EPA and DHA in fish oil nutritional capsules by GC-MS.Association between the intake of α-linolenic acid and the risk of CHD.Evaluation of a high-EPA oil from transgenic Camelina sativa in feeds for Atlantic salmon (Salmo salar L.): Effects on tissue fatty acid composition, histology and gene expression.The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.Nutritional Evaluation of an EPA-DHA Oil from Transgenic Camelina sativa in Feeds for Post-Smolt Atlantic Salmon (Salmo salar L.).Preliminary Validation of a High Docosahexaenoic Acid (DHA) and -Linolenic Acid (ALA) Dietary Oil Blend: Tissue Fatty Acid Composition and Liver Proteome Response in Atlantic Salmon (Salmo salar) Smolts.Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system.Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study.Association between the levels of polyunsaturated fatty acids and blood lipids in healthy individuals.Omega-3 fatty acid supplementation and cardiovascular disease.The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease.Effect of long chain omega-3 polyunsaturated fatty acids on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trialThe relationship between omega-3 and smoking habit: a cross-sectional study.Issues of fish consumption for cardiovascular disease risk reduction.Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetesEffects of oily fish intake on cardiovascular risk markers, cognitive function, and behavior in school-aged children: study protocol for a randomized controlled trialOverview of omega-3 Fatty Acid therapies
P2860
Q26747475-E4ED508A-EFC8-4ADD-B59D-93DB32DD8E82Q26772210-1E21A16C-EA9E-41EF-B07A-BCC0E50243E4Q26782277-9CB175A4-A1AF-4CB3-BA3F-FA8669CE6241Q26796303-771DEA20-CA23-4A07-A86C-02CE650BA8E9Q26852020-94D17FA1-EA4F-4E52-A1DD-B630582A4368Q27021694-ED5F2E39-9254-41AE-AC88-0108C55979CEQ27686781-F2E831DD-C28C-4B92-A466-8550B5964989Q28078517-F6445485-2974-4EAC-87E9-451B32B2EF71Q28080910-ABB2694A-6660-49CE-9659-F85D6FB88E26Q28251391-8CEF9D0A-64DD-472F-9406-50C044BDEEA8Q28387829-62DD344A-F382-40D8-A226-E95D02803803Q28972330-4C06E62E-0687-4121-BB50-3FC9EE20EFDFQ30538444-A4F2B97F-1B55-4E91-B1AF-C9FA3AE2B0F2Q30791902-390BCA2B-54FC-4A05-A6B1-8720B098E498Q33558765-D2E3EF86-4D2E-429A-838A-F6EA4C670781Q33586632-BF70A1A2-4DB3-4231-9128-28D35A5CA84CQ33748505-EF416BE6-D696-43A7-A5C7-BDE70886C1A3Q33820362-82B00D6B-0165-4D62-AE56-1449FE10E390Q33856033-7F66ECF2-E343-4C1C-B6D5-7697ECBC422CQ34212894-A4318C03-54AF-4617-84EE-13549EFCA21DQ34231280-F6FE4480-9136-47A8-BD7F-5A4EE2ED2121Q34587774-69DF8B06-B61A-49A0-B533-C124CF153829Q34822757-09D7BAEA-484C-44CD-B7D4-91DDAF40A450Q34908919-7DD45203-B4D5-4EC5-8EF1-BC0D60D4AF30Q34993427-50617166-56BB-4F13-BB48-819E41FD5759Q35694078-0E09A147-FED5-4BCA-8711-EC2AC578A4A0Q35817077-6242AA2A-8243-4FCA-9687-F655C57D8397Q36084839-50B2CDCB-EBE0-4EA6-BD47-C6B0C5424724Q36111275-70FAD867-19C0-4750-AE02-3ECB2028D6E4Q36115628-09AD9A0D-C01B-473F-B477-6C3527EB7327Q36370184-7E57167A-474E-4638-877F-00B029F1656DQ36386585-CFA580B6-FE2B-47EC-8CAE-D5D7FB4468EEQ36387184-7B49B2E8-4C27-4AFD-9D18-D0A11EE76314Q36495874-52A9900F-8609-424A-8B2A-C89BEB438483Q36524096-1BE580AD-E5D7-4E51-B0F6-1E472674289FQ36720400-0D5EF358-302A-4848-A70E-60335A80DB45Q36994049-ECBA4918-1DC8-4B51-B058-284D827542B4Q37308578-E2E4BDAC-5BEC-4FB2-82A6-9E611E192FB5Q37356873-72713BAF-C636-46C0-93B9-1B1F9EA22B0CQ37419411-3CAC1D0E-2BC1-47A5-A485-D16AE936DB29
P2860
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@ast
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@en
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@nl
type
label
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@ast
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@en
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@nl
prefLabel
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@ast
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@en
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.
@nl
P2093
P50
P1476
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review
@en
P2093
Francisco Perez-Jimenez
Javier Delgado-Lista
Jose Lopez-Miranda
Pablo Perez-Martinez
P304
P356
10.1017/S0007114512001596
P478
107 Suppl 2
P50
P577
2012-06-01T00:00:00Z